Category
- Press Release
- Regulatory
July 15, 2015
Stockholm, July 16, 2015 – U.S. Congress has passed a new bill called The Steve Gleason Act that improves the possibility for people with communication disabilities to receive public funding of speech-generating devices (SGDs) through Medicare. President Obama’s subsequent signing of the bill is expected to take place shortly. For Tobii Dynavox, which develops and sells both eye tracking and touchscreen-based assistive technology solutions, the new bill is likely to introduce more sales.
“Congressional passage and the subsequent signing by President Obama of The Steve Gleason Act is a victory for Medicare patients who rely on assistive technology to communicate with their loved ones and caregivers,” said Tara Rudnicki, the president of Tobii Dynavox’s North American Market Unit. “We look forward to a swift implementation of the legislation to ensure that patients who need this technology are able to have and keep their voices.”
About The Steve Gleason Act of 2015
Specifically, this bill aims to protect medically fragile beneficiaries by achieving two goals:
Tobii Dynavox is one of several organizations who have collaborated to ensure the passing of the bill, which is named after former NFL pro footballer Steve Gleason who has ALS and uses Tobii Dynavox products to communicate.
Tobii discloses this information pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was released for publication on July 16, 2015 at 00:10 a.m. CET.
Tobii is the global leader in eye tracking and pioneer of attention computing. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com.
July 15, 2015
Head of Investor Relations
+46 (0)72 219 82 15
Interim Head of Communications, Tobii
Tobii is the global leader in eye tracking and pioneer of attention computing. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com.